Schizophrenia Division

Medication

Antipsychotic medication is often the front-line treatment for schizophrenia.

Metabolic Health

This area of research focuses on individuals with psychosis who are experiencing metabolic problems or medication-related side-effects, such as weight gain and diabetes.

Genetics

Research shows that if a person’s family members experience schizophrenia, then that individual has a higher chance of developing this psychosis themselves.

Brain Chemistry

Brain chemicals, also known as neurotransmitters, are responsible for regulating internal bodily functions, influencing our behaviour and affecting how we react to medication.

Brain Imaging and Diagnostic Technology

Using advanced technology, scientists at CAMH can produce digital images of the brain and identify the affected areas in individuals experiencing schizophrenia.

Quality of Life

This area of research focuses on the effects schizophrenia can have on one’s life experiences, and how to improve quality of life for patients.